Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...
NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral ...
An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...
For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...
A new study found that your score on a key cardiovascular test may indicate your risk of dying in the coming years — even ...
The new pill, enlicitide, blocks a liver protein, PCSK9, that slows the body’s ability to clear cholesterol. With most PCSK9 blocked, LDL levels plummet and rates of heart attacks and strokes in high ...
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
8h
Coronary artery calcium may be a predictor for all-cause mortality, including non-cardiac conditions
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients ...
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...
The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.
NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback